Hyperbaric oxygen for severe skin infections
Part of Infections clinical trials.
This trial tests whether adding hyperbaric oxygen therapy to standard care helps adults with a serious soft-tissue infection. It could improve healing and reduce complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a confirmed severe soft-tissue infection (NSTI) that requires surgery
- You are not pregnant
- You are not being referred to palliative care
- You have no known allergy to the study drug
- You have no conditions that prevent hyperbaric oxygen treatment (like a collapsed lung)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a rare but serious infection called necrotizing soft-tissue infection (NSTI), which destroys tissue quickly. It looks at how patients are treated in hospitals across Europe to improve care.
This study checks if a new blood test (measuring carbon dioxide differences between veins and arteries) can help doctors better treat people with a severe infection in a high-pressure oxygen chamber. It is for critically ill patients already on life support.
This trial is testing whether hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can help heal diabetic foot ulcers. It is for people with diabetes who have a foot ulcer that is not healing well.
This study tests whether hyperbaric oxygen therapy (breathing pure oxygen in a special pressurized chamber) can help heal bone infections that develop after a leg injury. The therapy is given alongside surgery to clean and treat the infection.
This trial is testing whether giving extra oxygen in a special chamber (hyperbaric oxygen therapy) can help treat a serious, deep-skin infection. You may qualify if you've been diagnosed with this infection and are well enough for surgery.
This trial gives hyperbaric oxygen treatment to patients with conditions where it's not yet standard. It studies if the therapy can help people with emerging medical issues.
Hear when a new Necrotizing Soft Tissue Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.